We are live on ! Find out more
JNJ icon

Johnson & Johnson

3,677 hedge funds and large institutions have $365B invested in Johnson & Johnson in 2022 Q1 according to their latest regulatory filings, with 169 funds opening new positions, 1,680 increasing their positions, 1,450 reducing their positions, and 90 closing their positions.

New
Increased
Maintained
Reduced
Closed

88% more first-time investments, than exits

New positions opened: 169 | Existing positions closed: 90

42% more call options, than puts

Call options by funds: $3.29B | Put options by funds: $2.33B

35% more funds holding in top 10

Funds holding in top 10: 395532 (+137)

18% more capital invested

Capital invested by funds: $309B → $365B (+$55.8B)

16% more repeat investments, than reductions

Existing positions increased: 1,680 | Existing positions reduced: 1,450

1% more funds holding

Funds holding: 3,6453,677 (+32)

0.14% more ownership

Funds ownership: 69.01%69.15% (+0.14%)

Holders
3,677
Holders Change
+32
Holders Change %
+0.88%
% of All Funds
57.99%
Holding in Top 10
532
Holding in Top 10 Change
+137
Holding in Top 10 Change %
+34.68%
% of All Funds
8.39%
New
169
Increased
1,680
Reduced
1,450
Closed
90
Calls
$3.29B
Puts
$2.33B
Net Calls
+$968M
Net Calls Change
+$95.4M
Name Holding Trade Value Shares
Change
Change in
Stake
Creative Planning
201
Creative Planning
Kansas
$144M +$31.7M +186,162 +30%
WF
202
Welch & Forbes
Massachusetts
$142M +$1.72M +10,108 +1%
Swedbank
203
Swedbank
Sweden
$140M +$12M +70,468 +10%
Calamos Advisors
204
Calamos Advisors
Illinois
$139M +$19.8M +116,269 +17%
Zurich Cantonal Bank
205
Zurich Cantonal Bank
Switzerland
$139M +$6.19M +36,407 +5%
CWM
206
CIBC World Markets
New York
$139M -$91.2M -536,032 -41%
JFL
207
Jarislowsky, Fraser Ltd
Quebec, Canada
$138M -$4.96M -29,168 -4%
CA
208
Commerzbank Aktiengesellschaft
Germany
$137M +$5.29M +31,108 +4%
RFC
209
Regions Financial Corp
Alabama
$137M +$12.2M +71,730 +10%
HNB
210
Huntington National Bank
Ohio
$137M +$3.45M +20,252 +3%
AI
211
Ariel Investments
Illinois
$137M +$929K +5,459 +0.7%
Nisa Investment Advisors
212
Nisa Investment Advisors
Missouri
$136M -$24.7M -144,950 -16%
BTW
213
Boston Trust Walden
Massachusetts
$136M +$7.8M +45,865 +6%
GIA
214
Gateway Investment Advisers
Ohio
$133M +$1.1M +6,458 +0.9%
CIBC World Market
215
CIBC World Market
Ontario, Canada
$133M +$1.3M +7,652 +1%
Susquehanna International Group
216
Susquehanna International Group
Pennsylvania
$133M +$12.8M +75,353 +11%
Aviva
217
Aviva
United Kingdom
$131M -$20.3M -119,430 -14%
SI
218
Scharf Investments
California
$131M +$4.69M +27,588 +4%
HPC
219
HM Payson & Co
Maine
$130M +$2.71M +15,926 +2%
SOMRS
220
State of Michigan Retirement System
Michigan
$130M +$210K +1,237 +0.2%
AIG
221
American International Group
New York
$129M -$3.81M -22,415 -3%
AB
222
Amalgamated Bank
New York
$128M -$7.55M -44,356 -6%
AF
223
Amalgamated Financial
New York
$128M +$123M +722,797 New
ASRS
224
Arizona State Retirement System
Arizona
$128M +$238K +1,397 +0.2%
AC
225
Alleghany Corporation
New York
$128M

JNJ Hedge Fund Activity: Q1 2022 in Review

3,677 of the 6,341 institutional investors tracked by Wall St. Rank reported a position in Johnson & Johnson (JNJ) for Q1 2022, worth a combined $365B — up 18% from $309B a quarter earlier.

Buyers outnumbered sellers: 169 funds opened new JNJ positions and 90 closed out — a net gain of 79 holders — while 1,680 added to existing stakes and 1,450 trimmed.

The largest buyer was T. Rowe Price Associates, adding an estimated $1.06B. The largest seller was Fundsmith LLP, cutting an estimated $1.19B.

  • 3,677 institutional investors held Johnson & Johnson (JNJ) as of Q1 2022, up from 3,645 in Q4 2021.
  • Funds reported $365B of Johnson & Johnson stock for Q1 2022, up 18% quarter-over-quarter.
  • 169 funds opened new Johnson & Johnson positions in Q1 2022 and 90 closed out, a net change of +79 holders.
  • The largest Johnson & Johnson buyer in Q1 2022 was T. Rowe Price Associates, an estimated $1.06B added.
  • The largest Johnson & Johnson seller in Q1 2022 was Fundsmith LLP, an estimated $1.19B sold.

Based on aggregated 13F filings for Q1 2022.